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More than 80,000 chemicals are registered
for use in commerce in the United States, and
an estimated 2,000 new ones are introduced
annually. These chemicals are used in every-
day items such as foods, personal care prod-
ucts, prescription drugs, household cleaners,
and lawn care products [National Toxicology
Program (NTP) 2002]. Although environ-
mental health research has made great strides
in comprehending the impact of these chemi-
cals on human health, the sheer volume of
new chemicals being introduced daily com-
plicates our understanding of the compound
effects of multiple environmental exposures
on health over time.
In October 2002 the Society for Women’s
Health Research convened a thought leaders’
roundtable at the National Institute of
Environmental Health Sciences (NIEHS;
Research Triangle Park, NC) to discuss recent
advances in environmental health research,
particularly those ﬁndings that explain sex dif-
ferences in response to environmental expo-
sures. The environment plays a crucial role in
the etiology of many diseases, including can-
cers and disorders of the endocrine, nervous,
and immune systems. Understanding how
such agents disrupt biologic processes in both
sexes will allow us not only to prevent and
possibly cure many diseases and disorders but
also to explain their disproportionate impact
on men’s and women’s health.
Participants in this meeting presented
research from a broad spectrum of disciplines
ranging from immunology to behavior, using
both animal and human models for disease.
Their discussions, summarized in this article,
highlight the need for an interdisciplinary
approach to environmental health sciences.
An interdisciplinary approach is particularly
appropriate when addressing the questions
that arise when sex differences are looked for
and ultimately found. The study of sex differ-
ences is emerging as an important area of bio-
medical research, and this workshop illustrates
the complexities inherent in such studies,
which span endocrinology, molecular genetics,
microbiology, development, behavior, and
multiple generations.
The Environment and the
Immune System
The impact of the environment on the
immune system is well known. Malnutrition,
for example, can lead to a decrease in lym-
phocytes, particularly affecting the immature
CD4+ CD8+ cells, and to atrophy of lymphoid
tissue (Pallaro et al. 2001; Savino 2002).
Immunosuppressors such as cyclosporine and
FK-506, steroids, chemotherapeutic agents,
and other drugs can depress the immune sys-
tem (Medscape DrugInfo 2003; Patel et al.
2003), and environmental exposure to a vari-
ety of toxic chemicals such as dioxins, PCBs,
heavy metals, pesticides, herbicides, and par-
ticulates from burnt fossil fuel can reduce
immune responses and increase sensitivity to
infection (Selgrade et al. 1999). These diverse
chemical and biologic agents may act in very
different ways, and we have few clues regard-
ing the differential effects of chemical combi-
nations on the sexes and across generations.
Allen Silverstone, of the State University
of New York Upstate Medical University
(Syracuse, NY), showed that both corticoster-
oids and dioxin pollutants cause atrophy of
the thymus through very different mechanisms
of action. A single dose of dexamethasone
causes thymus atrophy in laboratory mice
within 48 hr, followed by a slow recovery over
the next 2 weeks. However, transgenic mice
expressing the human anti-apoptotic gene 
Bcl-2 are almost unaffected by the corticos-
teroid. In contrast, dioxins cause a more pro-
longed atrophy of the thymus that is only
slightly ameliorated by expression of the Bcl-2
gene. Indeed, the kinetics of dioxin-induced
thymic atrophy are more similar to those
caused by estrogen even though the hormone
and the toxin act on completely different
receptors (Lai et al. 2000; Silverstone et al.
1994; Staples et al. 1998a).
In addition to its effects on thymus tissue,
estrogen has many other immunomodulatory
actions, including inhibition of spleen T-cell
activation, up-regulation of speciﬁc cytokines
including interferon-γ and interleukin 4, and
an antiproliferative effect on blood stem cell
precursors. Could mimicking, disruption, or
exacerbation of these actions explain sex dif-
ferences in immune responses to environmen-
tal agents, or the disproportionately high
incidences of autoimmune diseases in women?
Some autoimmune animal models reveal sex-
speciﬁc patterns of disease and susceptibility
to chemical agents. New Zealand black mice
have an autoimmune response that leads to
red blood cell lysis and kidney damage; males
and females are equally affected. But crossing
these animals with normal Swiss Webster
mice generates female offspring that develop
a fully penetrant lethal nephritis—causing
death within 32–40 weeks—whereas the male
offspring develop very mild kidney damage,
do not start dying until 14 months of age,
and have no evidence of end-stage renal dis-
ease or autoimmunity in the ﬁrst year of life.
However, when Silverstone and Jerrie
Gavalchin of Cornell University (Ithaca, NY)
administered estradiol or dioxin once a
month to these male mice, they did develop
renal disease and just as rapidly as did their
female littermates (Silverstone AE, personal
communication).
Silverstone used radiation chimeras to
examine the contribution of specific cells to
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chimeras the host mouse is completely irradi-
ated, leaving the animal without hemato-
poietic stem cells or a functioning immune
system. The immune system is then reconsti-
tuted by injecting bone marrow cells from a
nonirradiated donor. The latter, however, can
be engineered without speciﬁc receptors, such
as those for estrogen or dioxin. When such
animals are used as donors, the resulting chi-
meras lack those receptors in the immune
system but express them normally in other
tissues (Gasiewicz et al. 2000).
Such chimeras have allowed Silverstone
and colleagues to conclude with certainty that
the dioxin-induced thymic atrophy is medi-
ated by direct activation of the receptor in a
small population of developing immune stem
cells (Staples et al. 1998b). Similar experi-
ments show that chimeras lacking estrogen
receptor α (ERα) in the immune system are
less sensitive to thymic atrophy induced by
estrogens, but even more surprising was the
discovery that a lack of ERα in nonhematopoi-
etic cells produces attenuated thymic atrophy
(Staples et al. 1999).
Women diagnosed with autoimmune
diseases suffer the burden of this interplay
between hormones such as estrogens and the
environment. For example, the incidence of
systemic lupus erythematosus, one of the
most common autoimmune diseases, is
10–15 times higher in women than in men
(Lupus Foundation of America 2003).
The exact causes and triggers of auto-
immune reactions are not fully understood,
but there are good indications that environ-
mental exposure to infectious and environ-
mental agents can play a crucial role. For
example, autoimmune myocarditis, one form
of which used to be known as rheumatic heart
disease, can directly result from an untreated
streptococcus infection (Dell et al. 1991). In
another example, contaminated cooking oil
was found to be responsible for an outbreak
of scleroderma-like symptoms among women
in Spain (Navas-Palacios et al. 1984).
Environmental hazards to the immune
system include heavy metals (Lawrence and
McCabe 2002), and more speciﬁcally, there is
an increasing body of evidence linking mer-
cury to autoimmunity (Nielsen and Hultman
2002). For example, there are reports showing
scleroderma patients who have the most
severe symptoms and highest anti-fibrillarin
titers, a marker of the disease, also have higher
levels of urinary mercury than do their less
symptomatic cohorts (Arnett et al. 2000).
Such studies have led Ellen Silbergeld of
Johns Hopkins University (Baltimore, MD)
to focus her attention on the role of mercury
in autoimmune diseases.
Silbergeld has found that mercury has a
profound impact on graft versus host disease
(GVHD) models of autoimmunity that
mimic lupus (Via et al. 2003). In these mod-
els, GVHD is induced by injecting spleno-
cytes from one strain of mice (C57BL/6 or
DBA/2) into hybrid offspring (C57BL/6 ×
DBA/2). Injecting the latter with splenocytes
from DBA/2 or BL/6 mice leads to chronic
and acute lupuslike disease, respectively, and
these mice usually start to die about a year
after the treatment. However, if inorganic
mercury is administered at concentrations as
low as 20 µg/kg to both the graft donor and
host before the grafting, the disease is acceler-
ated; 70% of these animals are moribund
after 2 months and all die within 4 months.
Hosts compromised by mercury also show
signiﬁcantly elevated proteinuria—up to four
times that of controls—and histopathologic
examination of their kidneys shows severe
lupuslike tissue damage not seen in sham-
grafted animals. Significantly, the latter
appear unaffected by these low doses of mer-
cury, whereas GVHD animals die of lupus—
not of mercury poisoning. Furthermore,
Silbergeld and colleagues observed stark sex
differences in the response of the hosts, males
being unaffected by the metal.
Mercury also has a profound effect in
models of cardiac myocarditis (CM). In auto-
immune CM, cardiac myosin is the major
antigen that is targeted by the immune system.
In fact, inoculating animals with this protein
can induce the disease. Mercury-treated mice
develop cardiomyopathy, have impaired car-
diac function, and show elevated levels of car-
diac myosin-speciﬁc IgG. If these animals are
given mercuric chloride (10 or 100 µg/kg)
before induction of CM, all these symptoms
are exacerbated, whereas control animals
appear unaffected by the metal. Precisely how
mercury modifies the immune response is
unclear. It may act as an adjuvant, suggested
Silbergeld, boosting autoimmune responses in
those already susceptible, or it may lead to
overactivation of lymphocytes. Sibergeld’s data
indicate that at relatively low doses, inorganic
mercury has profound effects on autoimmune
responses, suggesting that toxicity studies
should be carried out in the context of “co-
exposures.” Such studies could be conducted in
animals that are susceptible to autoimmunity.
These and similar experiments are paving
the way for additional studies that are needed
to elucidate immunotoxic effects of a variety
of chemicals in the environment. Essential to
our understanding of the interaction of the
hormones and the environment is the identi-
fication of specific cellular targets for toxic
agents that cause immune effects.
Heavy Metals and Steroid
Receptors
Other heavy metals may also have signiﬁcant
biologic effects. The research of Mary Beth
Martin, of Georgetown University Medical
Center (Washington, DC), has revealed that
divalent cations, including cadmium, copper,
vanadium, cobalt, mercury, and tin, may all
mimic to some extent the effect of estradiol on
cells expressing ERs. Martin and colleagues
have extensively studied the estrogenic-like
effects of cadmium in cell cultures and in
mouse model systems. Cadmium chloride,
they have found, will promote growth of the
MCF-7 human breast cancer cell line, cells that
are normally amitotic in the absence of estra-
diol. This growth is accompanied by a decrease
in expression of ERα and increases in levels of
the progesterone receptors PS2 and cathepsin
D, responses that are typical of growth induc-
tion by estradiol (Garcia-Morales et al. 1994).
But how exactly does cadmium elicit these
responses? Signal transduction through the
ER requires a translocation of the hormone/
receptor complex to the nucleus, where it can
bind to estrogen response elements that bestow
estrogen sensitivity on target genes. Cadmium
could conceivably act anywhere along this path-
way, or it could act indirectly through non-
speciﬁc interactions that impinge on estrogen
signal transduction. The evidence, however,
overwhelmingly favors the former scenario. The
estrogen antagonist ICI 164384, for example,
attenuates the effects of cadmium on gene
expression. In MCF-7 cells, either estradiol or
micromolar levels of CdCl2 will induce a 4-fold
increase in expression of the progesterone recep-
tor, but both of these actions are blocked by the
antagonist. Furthermore, in COS-1 cells, which
are devoid of ERs, chloramphenicol acetyltrans-
ferase (CAT) reporter genes engineered with
estrogen response elements are activated by cad-
mium only when the cells are also transfected
with ER genes, clearly implicating the receptor
in cadmium signaling (Stoica et al. 2000b).
ERs, like the rest of the steroid hormone
receptor family, have a hormone-binding
domain and a DNA-binding domain that is
dominated by zinc-ﬁnger motifs. The presence
of this other heavy metal in the receptor
suggested that this may be where cadmium
could introduce itself into the signal transduc-
tion pathway. As it turns out, the zinc-ﬁnger
domain is dispensable for cadmium’s actions.
Martin demonstrated this by using COS cells
transfected with chimeric receptors that con-
tain an estrogen-binding domain linked to
a GAL4 DNA binding domain. When these
cells are challenged with estradiol, the chime-
ras induce expression of GAL-driven CAT
reporters. A similar induction is achieved with
micromolar levels of cadmium, and both
responses are blocked by estrogen antagonists
(Stoica et al. 2000a).
These findings indicate that cadmium
binds to the estrogen-binding domain of the
receptor. But although Scatchard plots show
that cadmium’s affinity for the receptor is
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they also indicate that the metal and steroid
do not compete for binding to the receptor.
Likely sites where the metal could bind
include some that are near aspartic acid, glu-
tamic acid, and histidine residues, which
could provide the necessary ligand field to
chelate the atom. Crystallographic data pre-
dict several likely binding sites, and by muta-
tional analysis Martin confirmed the role of
glutamine 523, histidine 524, and aspartic
acid 538 in mediating the estradiol-like action
of the metal—introducing an alanine in each
of these positions that has no impact on estra-
diol activity but prevents activation of the
receptor by cadmium.
These amino acids lie in a loop between
alpha-helices 11 and 12 of the hormone-
binding domain. Helix 12 is particularly
important because in the absence of the
steroid it binds to heat shock proteins. These
keep the hormone-binding pocket open and
prevent the binding of co-activators, which are
necessary for activation of transcription. Martin
predicts that when cadmium binds to the loop
between helices 11 and 12 the heat shock pro-
teins are displaced, allowing co-activators to
bind, turning the ligand-free receptor into a
potent transcription messenger.
The action of cadmium is not restricted
to cultured cells. In vivo, at levels approaching
environmental exposures, the metal has pro-
found effects on uterine and breast tissue. In
ovariectomized mice given a single intraperi-
toneal dose of cadmium (2 µg/kg), the uterine
size almost doubled after 4 days. These results
are comparable with those in animals receiv-
ing hormone replacement. Similarly, mam-
mary gland tissue increased by about 50%
4 days after administration of the metal but
after 14 days increased more than 30-fold.
Cadmium also affects mice in utero. As little
as 0.5 µg/kg given to pregnant females at day
12 of gestation causes acceleration in the
development of the reproductive organs of
the pups (Johnson et al. 2003).
Martin has found that cadmium can also
activate androgen receptors. LN CaP cells, a
prostate cancer cell line that requires androgen
for growth, will proliferate in the presence of
cadmium. In a series of experiments that paral-
lel those described above, Martin and col-
leagues have shown that Cd2+ also binds to the
androgen receptor with high afﬁnity and non-
competitively with respect to free androgen
(Martin et al. 2002). These findings could
explain recent epidemiologic observations that
correlate elevated levels of the metal in benign
prostatic hyperplasia samples (0.98 µg/g Cd2+)
and prostate tumors (8.8 µg/g Cd2+) versus
normal tissue (0.7 µg/g Cd2+).
The effects of cadmium on mammary
glands and the prostate raise the question of
what other organs and tissue may be adversely
affected by this metal. Gonadal steroid recep-
tors are found in many nonreproductive organs
including the liver, blood vessels, and brain.
Further research is needed to elucidate the
impact of mercury, cadmium, and other toxins
acting through this mechanism.
Cancer and the Environment
Although cadmium may be a factor in breast
and prostate cancer, the exact cause of most
human cancers is unknown. Environmental
exposure to varied and multiple carcinogens
does play a role in the growth of some can-
cers, but the fact that some smokers die early
of lung cancer whereas others live to old age
to die of some other illness indicates that
other factors must predispose certain individ-
uals to cancer. These predispositions or indi-
vidual susceptibilities could result from sex,
race, socioeconomic status, or behavioral or
genetic differences. Age may play a role, but
the suggestion that accumulating carcinogens
or carcinogenic insults are responsible for the
age-related increase in the incidence of can-
cers is challenged by the fact that after middle
age the increase in cancer incidence slows.
Nevertheless, these three factors—predisposi-
tion, age, and environment—have been used
to explain carcinogenesis in the simplest terms
(American Cancer Society 2003). Although
predisposition and age cannot be altered, pri-
mary prevention may be achieved only by
reducing environmental exposure. This fact
alone should make the identiﬁcation of chem-
ical carcinogens a priority (Schmahl 1988).
James Huff, from the NIEHS, and col-
leagues use animal models of experimental
carcinogenesis to identify potential human
carcinogens. These studies supplement, and
most often precede, epidemiologic, clinical,
and other studies, such as those on cancer
clusters or occupational or environmental
exposures, which are reported for human
populations.
Chemically induced carcinogenesis in
animals must be carefully evaluated, however,
because the response to a given chemical may
occur only in a tissue or organ that has no
counterpart in humans, or in a particular
species or sex, the latter being vitally impor-
tant because it often indicates sex hormone
mediation. Years ago there was almost univer-
sal consensus that both sexes of an animal had
to elicit the same carcinogenic response from
a chemical or the result was considered sus-
pect. In addition, although some of the most
common human cancers, breast and lung, for
example, can be induced in animals, there are
also some human tumors, including prostate
and colorectal, that are not typically observed
in rodents.
Huff stressed that all human carcinogens
that have been tested in animal bioassays are
also carcinogenic in animals. Further, nearly
one-third of the identified human chemical
carcinogens were first discovered in animals
and only later in humans, adding consider-
able support for the validity of animal bio-
assays. Despite these findings, the use of
bioassay results to predict the public health
significance of environmental exposures
remains controversial.
As Huff outlined, predicting carcinogenesis
on the basis of chemical activity, such as muta-
genicity, toxicity, or structural formula, is not a
fully reliable methodology. He and colleagues
used this approach for 400 different chemicals.
Of 267 chemicals suspected strongly of being
carcinogens, only 181 (68%) returned positive
evidence in bioassays. This result points to the
inherent difficulties in predicting chemical
carcinogenesis and strengthens the rationale
that animal studies are essential for protecting
human health (Fung et al. 1995).
The issue of sex differences is difﬁcult to
address in these model systems because there
are not always animal correlates to human can-
cers. Animals almost never get prostate cancer,
for example, but appropriate models are being
developed. Methylnitrosourea is a known
prostate carcinogen, and it would be interest-
ing, Huff postulated, to expose strains of rats
and mice to this agent to ﬁnd an animal that
would be a good model for prostate-specific
carcinogens. However, such models may be
fraught with pitfalls. For example, if one were
to test a mammary gland carcinogen on a
prostate model and nothing happened, how
would one interpret the data? Single-organ
models may be most useful for discerning
mechanistic insights or for conﬁrming human
evidence. The two-species, two-sexes bioassay
should remain the accepted approach to identi-
fying environmental and human carcinogens.
Kent Hunter, of the National Cancer
Institute (Bethesda, MA), has done similar
work on this theme by exploring genetic and
environmental factors that influence sex-
specific cancers. Hunter and colleagues use
transgenic mice that develop multifocal mam-
mary tumors to study the genetics and
environmental influences on breast cancers
and their metastases. These mice express the
polyoma middle T gene, which causes cancer
by 9 weeks and rampant metastatic disease by
the time the animals are 100 days old.
In genetic screens Hunter and colleagues
crossed their highly tumorigenic mice with
normal inbred mice (> 25 strains) and exam-
ined their offspring for cancer and metastases.
Remarkably, some of these offspring had
tumors that were very poor at metastasizing,
and by back-crossing these animals with their
cancer-free parents, Hunter and colleagues
tried to pinpoint the genes responsible for
this trait. Crosses and back-crosses carried out
with different strains revealed common “hot
spots” on several chromosomes, including
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static phenotype. In chromosome 9, one of
these “hot spots” contained two genes that are
known to be involved in cancer: the tumor
suppressor gene ATM and the gene for Chk1,
which functions in the repair of damaged
DNA (Hunter et al. 2001; Lifsted et al. 1998).
Hunter and colleagues isolated and
sequenced these genes and found many poly-
morphisms across strains that may explain the
varying numbers of metastases seen in the orig-
inal crosses. One way to test this hypothesis
would be to make transgenic knockouts that
lack either or both of these genes. An alterna-
tive test would be to use a drug or chemical
that inhibits ATM or Chk1. Such molecules
have already been reported in the literature and
include caffeine.
Hunter and colleagues examined the effect
of caffeine on the transgenic mouse model by
administering drinking water with a caffeine
concentration typically found in green tea.
Mice were given the stimulant either at wean-
ing or after the first tumors developed
(~60 days). Both regimens reduced the total
tumor burden, although this was statistically
signiﬁcant only for animals taking the stimu-
lant upon weaning. Furthermore, the
metastatic potential of the tumors was signiﬁ-
cantly reduced in both groups of animals
(Yang H, unpublished data).
This effect is actually opposite to what one
would have predicted if a tumor suppressor
were being inhibited. One explanation for these
surprising results could be that caffeine sup-
presses the ability of the primary tumors to
form, thus lowering the total number of tumors
and, concomitantly, the number of metastases.
Hunter tested this hypothesis by examining the
histology of the mammary glands. But instead
of seeing a reduction in the number of tumors,
what was observed was a complete transforma-
tion of the mammary tissue.
Carcinogenesis is a complex, multifactorial
process rooted in the interaction of an organ-
ism with its environment. Sex is just one of
the factors that can determine whether a
potentially carcinogenic exposure results in
disease. Elucidating the roles and interaction
of carcinogens with gonadal steroids and their
receptors and target tissues is critical to a fuller
understanding of carcinogenesis.
Endocrine Disruptors
There are almost 100 known endocrine-
disrupting chemicals (EDCs) that may alter the
function(s) of the endocrine system and conse-
quently cause adverse health effects in intact
organisms, their progeny, or subpopulations.
Such disruptors include many commonly used
chemicals, such as organohalides, pesticides,
and phthalates that are used in plastics. In
addition to the known endocrine disruptors,
the U.S. Environmental Protection Agency
(EPA) estimates that there are > 80,000 poten-
tial EDCs that need to be evaluated for
endocrine effects (U.S. EPA 2003).
Some of these effects are sexually dimor-
phic. In females EDCs have been linked to
impaired fertility, increased incidences of uter-
ine and fallopian tube abnormalities, breast
and reproductive tract cancers, and endome-
triosis (Hodges et al. 2000; Iguchi et al. 2001;
Safe 2000). The latter can be induced in pri-
mates by extremely low levels of dioxin, about
25 ppt (Rier et al. 1993, 1995). In males
EDCs have been linked to declining sperm
counts (although this has been hotly debated),
increases in incidence of prostate and testicular
cancer, and deformities of the reproductive
tract; the incidence of the latter has doubled
over the last 20 years. In both sexes EDCs can
affect the immune system, lead to behavioral
changes, and have multigenerational effects
(Damstra et al. 2002).
Although, by deﬁnition, all EDCs act on
the endocrine system, they may act in very
different ways. They can alter enzyme action,
bind to receptors, affect metabolism and hor-
mone availability, or alter gene expression. All
this is complicated by the fact that natural
systems are also heterogeneous and have, for
example, multiple closely related hormones
(e.g., testosterone and dihydrotestosterone)
and receptor subtypes (e.g., ERα, ERβ).
There are also species-speciﬁc hormone varia-
tions and effects that need to be considered.
Whereas testosterone is the predominant
androgen in most vertebrates, 11-ketotestos-
terone is used by fish. Prolactin in humans
and other mammals promotes milk produc-
tion by mammary tissue, but in amphibians it
helps regulate metamorphosis and is necessary
for limb regeneration.
Dose relationships are not easy to inter-
pret, either, because some EDCs do not have
typical monotonic dose–response curves. In
rodents, increasing doses of diethylstilbestrol
to 0.2 µg/kg, for example, produces larger
prostate sizes, but if the dose is increased much
further, the prostate mass drops below that of
controls (vom Saal et al. 1997). Furthermore,
when animals are exposed to more than one
EDC, the impact may be much greater than the
sum of individual exposures (Silva et al. 2002).
However, because the endocrine system regu-
lates anatomical development, a single low-dose
exposure can have major consequences.
Critical windows for different organ sys-
tems also vary considerably. In humans, for
example, although the major limbs are fully
developed by 10 weeks, the central nervous
system and genitals continue developing right
up to birth. In amphibians, the discovery of
multiple limbs and digits caused great public
and scientiﬁc concern. Wildlife biologists were
initially stumped by these deformities because
no endocrine disruptor could be found to
elicit such altered patterns of development.
Subsequently, it was found that the deformi-
ties can be caused by trematode infections,
and that exposing the amphibians to endo-
crine disruptors, such as those found in agri-
cultural runoff, increases their susceptibility to
the parasite and to developmental abnormali-
ties. Indeed, in frog populations exposed to
trematodes, concomitant agricultural runoff
causes four to six times more deformities com-
pared with populations not exposed to runoff
(Kiesecker 2002).
Brent Palmer, of the University of Kentucky
(Lexington, KY) has found that developmental
susceptibility also arises in salamanders, which
are sensitive to a wide range of EDCs, including
atrazine, carbaryl, endosulfan, and octylphenol.
His group has found that embryonic exposure
to these chemicals may cause increased mortal-
ity, reduced growth, and behavioral problems
(Rehage et al. 2002).
Salamanders must balance their time
between foraging for food and seeking shelter
from predators. Endosulfan (10 ppb), octyl-
phenol (500 ppb), and atrazine (400 ppb) sig-
niﬁcantly alter activity patterns in salamanders.
Endosulfan and octylphenol make the animals
lethargic, preventing them from foraging for
food. In addition, the EDC-treated animals
show a greater tendency to move after being
disturbed. Exposure to 400 ppb atrazine, for
example, nearly doubles the chances that a sala-
mander will respond to a disturbance by mov-
ing instead of seeking cover. In natural settings,
this leaves the animals open to attack by preda-
tors (Rohr et al. 2003) and has the possibility
of wiping out the population.
These experiments reveal the profound
impact that endocrine disruptors can have in
the wild. Palmer and colleagues are presently
building computer models to study how these
and similar effects can affect whole popula-
tions. The impact can also be multigenera-
tional, he reminded workshop participants.
For example, studies have shown that for
humans exposed to PCB-contaminated cook-
ing oil, the sex ratio of their offspring was dra-
matically altered. The proportion of boys
dropped from an average of about 55% in the
normal population to as low as 40% in those
exposed to PCB (del Rio Gomez et al. 2002).
Other population effects may go unreported,
suggested Palmer, because the Gaussian distri-
bution of a particular response is not shifted
left or right by exposure to a disruptor, but
instead the curve tends to flatten because of
increased variation. Those affected are often
the outliers in the curve, he theorized, and
unless the sample numbers are very large this
fact may go undetected.
Bernard Weiss, University of Rochester
School of Medicine and Dentistry (Rochester,
NY) also reported that there is considerable
sexual dimorphism in behavioral responses to
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not previously been shown to affect wheel-run-
ning patterns in rodents, but Weiss and col-
leagues delved further into these behaviors and
made some interesting observations.
In normal rats, wheel running is a sexually
dimorphic behavior. In females, the amount
of running is correlated with the stage of the
estrous cycle, and they also run more than
their male littermates. Weiss and colleagues
set up an experiment in which the animals
were trained to press a lever a speciﬁc number
of times to gain access to a single period of
activity on the running wheel. The number
of times the lever had to be pressed varied
from one (fixed ratio of one; FR1) to 30
(FR30). The researchers adopted this situa-
tion to measure the motivation to run rather
than simply measuring spontaneous running.
To test his hypothesis that dioxin influences
female brain development, Weiss gave preg-
nant mothers a single dose of the dioxin
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD;
between 0 and 180 ng/kg) at day 18 of ges-
tation. When the offspring were 5 months
of age, they were trained and tested in the
modiﬁed running wheel.
Weiss and colleagues found that the
dioxin-treated female rats pressed the lever
fewer times and earned fewer opportunities to
run than did controls. Signiﬁcantly, the dose–
response curve for this outcome suggests that
an ED10 (the dose required to produce a 10%
change in performance) would be about
7 ng/kg, within the range of the known dioxin
burden of the human population that was
calculated to average 13 ng/kg in 1995 based
on the sum of TCDD and related agents
(Markowski et al. 2001).
Weiss and colleagues also used a schedule-
controlled operant behavior regimen to test
the effects of the same exposure to dioxin but
at day 8 of gestation. In this experiment, the
animals received a reward for tapping a lever a
set number of times (which was progressively
raised from 1 to 71) or, on another schedule,
for waiting at least 10 sec between successive
lever responses. Normally, males press the
lever more frequently than their female litter-
mates. In this experiment, however, dioxin
had the opposite effect on male and female
offspring. Males from treated mothers
responded at lower rates than did males of
untreated mothers, whereas females of treated
mothers responded at higher rates than did
control females. At intermediate doses of
dioxin (60 ng/kg), the dioxin-treated female
offspring actually outperformed control males
(Hojo et al. 2002).
These sex differences in response to dioxin
may be related to differences that already exist
in the animals. In humans, male brains are
known to be more asymmetrical and to have
proportionately more white matter than those
of their female counterparts, whereas in rats
males have thicker right cerebral cortices,
higher cell counts in the right hemisphere, and
more ERs in the right neonatal cortex. These
biases are all reversed in female animals whose
mothers were given dioxin. Could the effect of
dioxin on female rats be caused by altered
patterns of development in the brain? Weiss
and colleagues examined the depth of the cere-
bral cortices in offspring of rats that had been
treated at gestation day 8 with the highest
levels of dioxin (180 ng/kg) and found that
the normal lateralization—thicker left hemi-
sphere—was reversed, indicating that the
female brains had been “masculinized.”
Genomics
In exploring sex differences such as those
discussed in this article, the ultimate goal must
be to elucidate the biologic pathways or activi-
ties that are affected by environmental expo-
sure. Before the genomics era, this task seemed
insurmountable, but the recent completion of
the human, mouse, yeast, and other model
genomes, coupled with the arrival of a suite of
genomic and proteomic tools that accelerate
the accumulation of biologic data, has pro-
vided the means and opportunity to carry out
the required experiments.
Mary Jane Cunningham, currently with
the Houston Advanced Research Center
(Houston, TX) and formerly from the
Molecular Mining Corporation (Kingston,
Ontario, Canada), has used genomic tools to
probe the effects chemicals have on gene
expression in both male and female rats. By
comparing cDNA libraries made from treated
and untreated animals, Cunningham and col-
leagues have shown that administration of
prototypical hepatotoxins, such as carbon
tetrachloride, fenofibrate, and hydrazine,
along with less toxic chemicals such as aceta-
minophen and cloﬁbrate increases expression
of specific genes in the liver. Some of these
genes, such as those for cytochrome P450 and
acetaminophen-binding protein, have a
known function, but many do not. By carry-
ing out subtractive hybridizations on samples
from male and female livers, Cunningham
was able to identify sex differences in the
response to these chemicals. For example,
both benzo[a]pyrene and cloﬁbrate cause the
same gene of unknown function (g2224669)
to appear more abundantly in females than
in males.
DNA microarrays have allowed Cunning-
ham and colleagues to compare and contrast
hepatocyte gene expression patterns in animals
that have been treated in vivo with chemical
agents. Acetaminophen, benzo[a]pyrene, and
cloﬁbrate, three compounds that affect differ-
ent metabolic and detoxification pathways,
cause significant up- or down-regulation of
269, 146, and 271 genes, respectively, out of a
total of 7,400 selected for the array. Although
the expression proﬁles for each of these treat-
ments were unique, some commonly regulated
genes exist and may represent toxicity markers,
but these were few. Of the 172, 186, or 60
genes that were affected by acetaminophen,
benzo[a]pyrene, or clofibrate, respectively
(after more stringent ﬁltering of the data using
the signal of the arrayed spot ≥ 40%, ratio of
signal to background ≥ 2.0, and spot intensity
≥ 250), only nine (or 3%) were found to
be common.
Microarray analysis is also a useful tool for
analyzing how responses to drugs or toxic
agents differ between males and females.
Cunningham has found that when rats are
challenged with cloﬁbrate, several genes are up-
regulated and down-regulated in female livers
compared with their male peers, a result that
was mirrored by analysis of the liver proteome.
It is noteworthy, perhaps, that of the genes that
are disproportionately down-regulated in
female liver tissue, one is the liver-regenera-
tion–related protein, which is involved in the
early liver regeneration response.
Although such high throughput tech-
niques hold the potential for advances in the
field of genomics and environmental health,
there is concern that much of this technology
and the data garnered from using it remain in
databases belonging to proprietary firms.
Industry should partner with agencies such as
the NTP (Research Triangle Park, NC) to cre-
ate transparent databanks that can be shared
among researchers at the earliest stage possible.
Such cross-industry collaboration will speed
scientific discovery and potentially affect the
health of millions of people as potential toxins
are identiﬁed.
Conclusions
By the end of this decade, experts predict that
more than 100,000 chemicals will be regis-
tered for commercial use in the United States
(NTP 2002). We come into contact with
these chemicals through the food we eat, the
air we breathe, the medications we take, and
the clothes we wear. We are continually learn-
ing more about how these compounds inter-
act with the body and the long-term impact
of these interactions on health. The emerging
field of sex-based biology is revealing that
these interactions can differ between women
and men.
Environmental exposures can affect organ-
isms from cellular function through behavior.
New research approaches are needed for us
to understand better the interaction of these
exposures with biologic sex differences. Crucial
to the success of such scientiﬁc exploration is
hypothesis-driven research and the support of
investigator-initiated research by federal agen-
cies. Additionally, the Society for Women’s
Health Research calls on environmental health
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researchers to include sex as a variable in all
data collection, including data derived from
cell lines and tissue cultures.
To fully understand the potential effect of
chronic exposures on the sexes, researchers
need to develop models to explore not only
physiologic sex differences but also behavioral
responses to low-dose and multiple chemical
exposures. Additionally, researchers should
track these responses across multiple genera-
tions to identify potential long-term risks of
exposures and the influence of sex on that
risk. Incorporated in this approach should be
a better understanding of which end points
one needs to examine. A multidisciplinary
approach to environmental health research is
central to fostering discovery. As we learn
more about the mechanisms of environmen-
tally related diseases, we see that exposures
can affect the individual across multiple organ
systems. Only by working across disciplines
will we be able to fully understand the impact
of the environment on health.
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